Maasstad Ziekenhuis Stichting

The department focuses on improving outcomes for patients with ischemic stroke and transient ischemic attack, evaluating new antithrombotic strategies and optimizing post‑stroke care.

• Stroke prevention therapies
• Antiplatelet and anticoagulant safety
• Quality of life after stroke

Research at Maasstad Ziekenhuis Stichting aims to reduce recurrent events while balancing bleeding risk, offering patients safer long‑term protection.

Studies target chronic inflammation of the pancreas, seeking better pain control and disease management for individuals with chronic pancreatitis.

• Analgesic optimization
• Impact on daily functioning
• Early intervention strategies

The goal is to enhance comfort and reduce reliance on high‑dose medications for affected patients.

Research explores fertility support, including hormonal and procedural adjuncts to improve live‑birth rates for couples facing unexplained subfertility.

• Luteal phase support efficacy
• Cost‑effectiveness of adjunct therapies
• Outcomes of mild ovarian stimulation

By refining treatment protocols, the site seeks to increase successful pregnancies with minimal intervention.

Clinical work evaluates treatment duration and quality of life for men with prostate cancer, focusing on androgen‑targeted therapies and rehabilitation.

• Shortened androgen receptor inhibitor use
• Metastatic castration‑sensitive prostate cancer outcomes
• Penile rehabilitation strategies

The investigations aim to maintain disease control while reducing side effects and preserving sexual health.

A broad oncology program addresses blood cancers and solid tumors, testing novel immunotherapies and targeted agents for diseases such as diffuse large B‑cell lymphoma, multiple myeloma, and chronic lymphocytic leukemia.

• Immunotherapy consolidation after chemotherapy
• Fixed‑duration combination regimens
• Minimal residual disease monitoring

Efforts are directed toward extending remission periods and improving survival without increasing toxicity.

The site conducts studies on antiretroviral management for individuals living with human immunodeficiency virus (HIV), focusing on regimen simplification and sustained viral suppression.

• Switch to single‑tablet therapy
• Long‑term safety in older adults
• Maintenance of virologic control

Findings aim to enhance adherence and quality of life for patients on chronic HIV treatment.

Investigations address normal and pathological processes of the urinary and reproductive systems, including erectile function recovery and fertility enhancement.

• Sildenafil dosing strategies for erection quality
• Role of hormonal support in assisted reproduction
• Physiological outcomes after urological interventions

The department seeks to translate physiological insights into practical therapies that improve patient well‑being.